Evolución clínica y angiográfica de las lesiones dilatadas en el segmento proximal de la arteria coronaria descendente anterior: stent frente a balón

Moreno, Pedro Marcos-Alberca; Romo, Andrés Íñiguez; Amo, Felipe Navarro del; Antolín, José María Serrano; Hernández, Rosendo Ibargollín; Belenguer, Ricardo García; Paz, José de la

doi:10.1016/s0300-8932(99)74892-x

Cited by 5 publications

(4 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Restenosis and new revascularization rates after the first year for bare metal stents vary between 19% and 31% of pa- tients. 21,27,30,31 Our group 32 and another 33 have shown high event-free survival rates in a very long follow-up (5 years) with TLR rates of 12.2-15%.…”

Section: Discussionmentioning

confidence: 66%

“…Proximal locations of coronary lesions and LAD have been reported as predictors of restenosis 26 . Stenting has clearly modified these results by achieving a reduction of almost 50% of the restenosis risk, 9,27–30 a low incidence of periprocedural complications, and a favorable long‐term prognosis (similar to IMA surgery). Restenosis and new revascularization rates after the first year for bare metal stents vary between 19% and 31% of patients 21,27,30,31 .…”

mentioning

confidence: 99%

“…Stenting has clearly modified these results by achieving a reduction of almost 50% of the restenosis risk, 9,27–30 a low incidence of periprocedural complications, and a favorable long‐term prognosis (similar to IMA surgery). Restenosis and new revascularization rates after the first year for bare metal stents vary between 19% and 31% of patients 21,27,30,31 . Our group 32 and another 33 have shown high event‐free survival rates in a very long follow‐up (5 years) with TLR rates of 12.2–15%.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Two‐Year Follow‐up of Sirolimus‐Eluting Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis

Valencia¹,

Berenguer²,

Mainar³

et al. 2006

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 66%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Two‐Year Follow‐up of Sirolimus‐Eluting Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis

Valencia¹,

Berenguer²,

Mainar³

et al. 2006

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

“…for the treatment of these lesions (2,3,4,5,6). Nevertheless, restenosis has become the Achilles heel for stenting.…”

Section: Original Articlementioning

confidence: 99%

Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis

Martín,

Mainar

2007

Int. J Biomed Sci.

View full text Add to dashboard Cite

Sirolimus-eluting stents (SES) have demonstrated low incidence of target vessel revascularizations in several anatomic scenarios, including proximal left anterior descending coronary artery (pLAD) lesions. The aim of present study was to compare the efficacy of SES with bare metal stents (BMS) for the treatment of such lesions. 96 patients with severe pLAD stenosis treated with SES were included. Clinical follow-up were performed during a 24 month period. A 98 patient sample with pLAD lesions treated with BMS was taken as control group. Death, angiographic restenosis, new target lesion revascularization (TLR) and target vessel failure (TVF) were registered. Clinical, angiographic and procedural variables were analysed to identify predictors of TVF and TLR. Angiographic procedural success was 100% in SES group vs 99% in BMS group (p=1.0). At 2.5 years, the cumulative rate of TVF was 9.4% in SES group vs 16.3% in BMS group (p=0.15), and the rate of TLR was 5.2% in SES group vs 12.2% in control group (p=0.08). The probabilities of cumulative TVF and TLR free survival were in BMS group 83.7% and 87.8%, and in SES group 90.6% and 94.8%, respectively. After multivariate analysis only SES utilization was found as independent protective factor against TVF and TLR (HR 0.38, 95%CI [0.15-0.94] p=0.037 and HR 0.21, 95%CI [0.06-0.66] p=0.008, respectively), and diabetes as independent predictor of TFV and TLR (HR 2.37, 95%CI [1.07-5.24] p=0.034 and HR 3.57, 95%CI [1.29-9.87] p=0.014, respectively). This study demonstrates that SES utilization is safe and effective in the tretament of pLAD lesions with a better clinical outcome than BMS in a long-term follow-up.

show abstract

Utilidad de los predictores de reestenosis angiográfica en la predicción de reestenosis clínica de stents intracoronarios

Pascual-Figal

Chávarri

Aracil

et al. 2000

Revista Española de Cardiología

View full text Add to dashboard Cite

Evolución clínica y angiográfica de las lesiones dilatadas en el segmento proximal de la arteria coronaria descendente anterior: stent frente a balón

Cited by 5 publications

References 20 publications

Two‐Year Follow‐up of Sirolimus‐Eluting Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis

Two‐Year Follow‐up of Sirolimus‐Eluting Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis

Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis

Utilidad de los predictores de reestenosis angiográfica en la predicción de reestenosis clínica de stents intracoronarios

Contact Info

Product

Resources

About